Notice Of Intent To Sole Source The Production Of Two Lots Of Iso Quality Level Full Genome Synthetic Sars-Cov-2 Rna Positive Control (Part: 103727) From Twist Bioscience

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 81331725

  Document Type - Tender Notices

Description - The Centers for Disease Control and Prevention intends to award a sole source firm-fixed-price purchase order to Twist Bioscience. The purpose of this acquisition is to obtain two (2) lots of 1020 kits (each) of ISO quality level full genome syntheti c SARS-CoV-2 RNA positive control (Part: 103727) that satisfies the specification of CDC influenza Division’s FDA-cleared diagnostic tests FluSC2 Multiplex Assay that is approved for Emergency Use Authorization (EUA) for detection of Influenza A, B, and SARS-CoV-2, the virus that causes COVID-19.  FDA will not allow any substitution of already approved essential materials that make up the assay that has been approved for EUA.  These materials

Gt Ref Id - 81331725

Deadline - May 09, 2024